Recombinant Human OV16 Protein，His

OV16 is a recombinant protein derived from the ovine (sheep) adenovirus, which has garnered attention in the field of veterinary medicine and immunology. With a focus on its potential applications in vaccine development, OV16 is of particular interest for its ability to elicit immune responses against various pathogens in livestock. Research has shown that adenoviruses can serve as effective vectors for delivering antigens, owing to their robust innate immunogenicity and ability to stimulate both humoral and cellular immune responses. The OV16 protein, when expressed as a recombinant entity, has been investigated for its role in enhancing immunity against viral infections in sheep and other ruminants. Studies have aimed to optimize its expression systems, enhance its stability, and evaluate its immunogenic properties through various formulations. The understanding of OV16's molecular structure and immunogenic profile is crucial to developing effective vaccines that can improve animal health and productivity. Furthermore, this research contributes to the broader field of transgenic biotechnology, highlighting the importance of recombinant proteins in disease control and prevention strategies in agriculture, ultimately aiming to ensure food security and reduce the reliance on antibiotics. As the global demand for livestock products continues to rise, the OV16 recombinant protein represents a promising avenue for advancing the health and productivity of livestock through innovative immunological approaches.